Covid-19 vaccine

Lipid nanoparticle mRNA vaccine
#Arcturus #BioNTech #Covid-19 vaccine #Moderna #mRNA #mRNA-based vaccines

The companies taking the lead on mRNA

DDW’s Diana Spencer takes a closer look at three companies hoping to be the first to bring new mRNA therapeutics to the market. Although the concept of using mRNA to make therapeutics or vaccines has been around for decades, it took the urgency of a global pandemic for it to… Read More

#Exclusive Content

T cell attacking Covid-19
#Covid-19 #Covid-19 vaccine #Immune response #Immunology / Virology & Vaccines #SARS-CoV-2 #T cell activation

Covid-19 causes long-term damage to the immune system

New findings suggest that the SARS-CoV-2 virus damages an important immune-cell response. The quality of CD8+ T cell response to two doses of the Pfizer-BioNTech Covid-19 vaccine was considerably lower in people with prior SARS-CoV-2 infection compared to people without prior infection, the US study found. Read More

#News #Trending News

Covid-19 vaccination
#Cardiovascular disease #Covid-19 #Covid-19 vaccine #Immunology / Virology & Vaccines

Covid-19 vaccination reduces risk of cardiac events

Researchers have revealed that vaccination against Covid-19 is associated with fewer heart attacks, strokes, and other cardiovascular issues among people who were infected with SARS-CoV-2.  The conclusions are based on analysis of the most extensive datasets in the United States by a team from the Icahn School… Read More

#News #Trending News

#Covid-19 #Covid-19 vaccine #Drug development #Drug discovery #Gene therapy #Geographic atrophy #Malaria #Monoclonal antibodies #Psychedelics #Treatment-resistant depression

This week in drug discovery (31 October – 4 November)

News round-up for 31 October – 4 November by DDW Digital Content Editor Diana Spencer  In a week that saw magic mushrooms making the headlines in the UK, we also reported on exciting potential new therapies for geographic atrophy and malaria prevention. Meanwhile, the quest to understand… Read More

#News

Preparing Covid-19 vaccine for injection
#Covid booster #Covid-19 #Covid-19 vaccine #MHRA #Phase III trial #Vaxxinity

New class of Covid-19 booster completes enrollment of Phase III trial

Global Phase III topline data is expected later this year for a new class of Covid-19 booster vaccine. Vaxxinity has completed enrollment for the trial, co-sponsored by the Coalition for Epidemic Preparedness Innovations (CEPI). Its UB-612 will be evaluated as a heterologous booster vaccine to mRNA, adeno-vectored, and inactivated primary… Read More

#Covid-19 #Editor's Choice #News

Covid-19 vaccination
#Covid-19 #Covid-19 vaccine #Immunocompromised #Immunology / Virology & Vaccines

Covid-19 vaccine less effective in the immunocompromised 

A new study in the US has revealed that the Covid-19 vaccine is less effective in people with weakened immune systems.  The research from the Centers for Disease Control and Prevention’s VISION Network analysed real-world data on mRNA vaccine effectiveness during Omicron BA.4 and BA.5 predominance… Read More

#Covid-19 #News #Trending News